302 related articles for article (PubMed ID: 32244769)
1. Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease.
Hsieh TH; Kuo CW; Hsieh KH; Shieh MJ; Peng CW; Chen YC; Chang YL; Huang YZ; Chen CC; Chang PK; Chen KY; Chen HY
Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32244769
[TBL] [Abstract][Full Text] [Related]
2. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
Ghaisas S; Langley MR; Palanisamy BN; Dutta S; Narayanaswamy K; Plummer PJ; Sarkar S; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2019 Dec; 75():186-199. PubMed ID: 31505196
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for Parkinson's disease: Current evidence and future directions.
Tan AH; Hor JW; Chong CW; Lim SY
JGH Open; 2021 Apr; 5(4):414-419. PubMed ID: 33860090
[TBL] [Abstract][Full Text] [Related]
4. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
Chen HH; Chang PC; Chen C; Chan MH
Pharmacol Rep; 2018 Aug; 70(4):668-676. PubMed ID: 29909247
[TBL] [Abstract][Full Text] [Related]
5. Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence.
Leta V; Ray Chaudhuri K; Milner O; Chung-Faye G; Metta V; Pariante CM; Borsini A
Brain Behav Immun; 2021 Nov; 98():59-73. PubMed ID: 34364965
[TBL] [Abstract][Full Text] [Related]
6. Probiotics for Parkinson's Disease.
Gazerani P
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450864
[TBL] [Abstract][Full Text] [Related]
7. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
8. Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
Langley M; Ghosh A; Charli A; Sarkar S; Ay M; Luo J; Zielonka J; Brenza T; Bennett B; Jin H; Ghaisas S; Schlichtmann B; Kim D; Anantharam V; Kanthasamy A; Narasimhan B; Kalyanaraman B; Kanthasamy AG
Antioxid Redox Signal; 2017 Nov; 27(14):1048-1066. PubMed ID: 28375739
[TBL] [Abstract][Full Text] [Related]
9. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Ekstrand MI; Galter D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
[TBL] [Abstract][Full Text] [Related]
10. GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.
Chen C; Li X; Ge G; Liu J; Biju KC; Laing SD; Qian Y; Ballard C; He Z; Masliah E; Clark RA; O'Connor JC; Li S
Sci Rep; 2018 Apr; 8(1):5460. PubMed ID: 29615705
[TBL] [Abstract][Full Text] [Related]
11. Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits in a Chronic MPTP/Probenecid Mouse Model of Parkinson's Disease.
Biju KC; Evans RC; Shrestha K; Carlisle DCB; Gelfond J; Clark RA
Neuroscience; 2018 Jun; 380():111-122. PubMed ID: 29684508
[TBL] [Abstract][Full Text] [Related]
12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
13. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the Combination of Probiotic Supplementation on Motor Symptoms and Constipation in Parkinson's Disease.
Alexoudi A; Kesidou L; Gatzonis S; Charalampopoulos C; Tsoga A
Cureus; 2023 Nov; 15(11):e49320. PubMed ID: 38146566
[TBL] [Abstract][Full Text] [Related]
15. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
Fifel K; Cooper HM
Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
[TBL] [Abstract][Full Text] [Related]
16. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease.
Li X; Redus L; Chen C; Martinez PA; Strong R; Li S; O'Connor JC
PLoS One; 2013; 8(8):e71341. PubMed ID: 23977020
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.
Ay M; Luo J; Langley M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
J Neurochem; 2017 Jun; 141(5):766-782. PubMed ID: 28376279
[TBL] [Abstract][Full Text] [Related]
19. Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.
Palasz E; Niewiadomski W; Gasiorowska A; Wysocka A; Stepniewska A; Niewiadomska G
Front Neurol; 2019; 10():1143. PubMed ID: 31736859
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Motor Cortical Electrical Stimulation Ameliorates 6-Hydroxydopamine-Induced Motor Dysfunctions and Exerts Neuroprotective Effects in a Rat Model of Parkinson's Disease.
Kuo CW; Chang MY; Chou MY; Pan CY; Peng CW; Tseng HC; Jen TY; He XK; Liu HH; Nguyen TXD; Chang PK; Hsieh TH
Front Aging Neurosci; 2022; 14():848380. PubMed ID: 35250550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
